The global infertility drugs market size reached US$ 3.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.7% during 2024-2032. Efforts to improve access to infertility treatments, including drug therapies, are contributing to market growth. Government initiatives, insurance coverage expansions, and the development of more affordable options are making infertility treatments more accessible to a wider population. This increased accessibility is driving demand for infertility drugs.